Effects of combined low-density lipoprotein apheresis and aggressive statin therapy on coronary calcified plaque as measured by computed tomography

Am J Cardiol. 2003 Feb 15;91(4):461-4. doi: 10.1016/s0002-9149(02)03248-4.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Administration, Oral
  • Aged
  • Anticholesteremic Agents / therapeutic use*
  • Atorvastatin
  • Blood Component Removal / methods*
  • Calcinosis / blood
  • Calcinosis / diagnostic imaging*
  • Calcinosis / genetics
  • Calcinosis / therapy*
  • Cholesterol, LDL / blood*
  • Combined Modality Therapy
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / diagnostic imaging*
  • Coronary Artery Disease / genetics
  • Coronary Artery Disease / therapy*
  • Drug Monitoring
  • Female
  • Follow-Up Studies
  • Heptanoic Acids / therapeutic use*
  • Heterozygote
  • Humans
  • Hyperlipoproteinemia Type II / complications*
  • Hyperlipoproteinemia Type II / genetics
  • Male
  • Middle Aged
  • Pyrroles / therapeutic use*
  • Severity of Illness Index
  • Simvastatin / therapeutic use*
  • Tomography, X-Ray Computed*
  • Treatment Outcome

Substances

  • Anticholesteremic Agents
  • Cholesterol, LDL
  • Heptanoic Acids
  • Pyrroles
  • Atorvastatin
  • Simvastatin